CFCThe Compounder Score
CRLBF logo

CRLBF — Cresco Labs Inc.

Drug Manufacturers - Specialty & GenericHealthcare

$0.50

+$0.02 (+4.82%)

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.

Market Cap

$188.59M

Forward P/E

-6.7x

52-Week Range

N/A

CRLBF Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$656M

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

$34.7M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-3.2%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

1.4x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

5.8%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+1.8%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).